| Literature DB >> 31931751 |
Anne Njeri Maina1, Leah Chebet Bii2.
Abstract
BACKGROUND: Hepatitis B Virus (HBV) is highly endemic in Sub-Saharan Africa with 70 to 90% of the population becoming infected before the age of 40 years. Healthcare workers (HCWs) including healthcare students (HCSs) are at an increased risk of contracting HBV due to occupational exposure. HCSs are especially at a high risk because of their inexperience with infection control procedures and insufficient knowledge about the level of risk when dealing with patients. Despite the availability of an effective vaccine, and its recommendation by Kenya's Ministry of Health, few HCW and students are vaccinated. The aim of this study was to evaluate the influence of awareness, attitude, practices, and access factors on hepatitis B vaccination uptake by HCSs at Kenya Medical Training College (KMTC).Entities:
Keywords: HBV vaccination; Health care Students; Kenya; Vaccine uptake
Mesh:
Substances:
Year: 2020 PMID: 31931751 PMCID: PMC6958794 DOI: 10.1186/s12889-020-8158-2
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Flow chart showing participant recruitment for the quantitative study
Demographic characteristics of the quantitative survey respondents
| Factors | Characteristic | Frequency | Percentage(%) |
|---|---|---|---|
| Age ( | Mean (Std.Dev) | 22.5 (2.81) | |
| Median | 22 | ||
| Range | 18,40 | ||
| Sex ( | Male | 239 | 49.2 |
| Female | 247 | 50.8 | |
| Campus ( | Kisii | 53 | 10.9 |
| Kakamega | 57 | 11.7 | |
| Nairobi | 215 | 44.2 | |
| Embu | 32 | 6.6 | |
| Eldoret | 60 | 12.4 | |
| Portreiz | 69 | 14.2 | |
| Department ( | Medical Laboratory Sciences | 83 | 17.5 |
| Nursing | 148 | 31.2 | |
| Biomedical Engineering | 50 | 10.6 | |
| Environmental Health | 32 | 6.8 | |
| Physiotherapy | 20 | 4.2 | |
| Medical Imaging Services | 26 | 5.5 | |
| Clinical Medicine | 58 | 12.2 | |
| Pharmacy | 57 | 12.0 | |
| Year of Study ( | 1st year | 118 | 24.3 |
| 2nd year | 158 | 32.5 | |
| 3rd year | 205 | 42.2 | |
| 4th year | 5 | 1.0 | |
| Duration at KMTC ( | < 1 year | 106 | 21.8 |
| 1 year | 71 | 14.6 | |
| 2 years | 106 | 21.8 | |
| 3 years | 190 | 39.1 | |
| > = 4 years | 13 | 2.7 |
Fig. 2Bar graph showing reported most important sources of information about vaccination across all study sites
Student responses to the known modes of transmission of HBV
| Which of the following are the modes of transmission of HBV?a | Yes | No n(%) |
|---|---|---|
| Transfusion of contaminated blood or blood products ( | 429 (95.1) | 22 (4.9) |
| Unprotected sexual intercourse ( | 310 (72.1) | 120 (27.9) |
| Mother to child transmission ( | 301 (75.0) | 106 (26.0) |
| Scarification, tattooing and shaving ( | 226 (59.3) | 155 (40.7) |
| Handling contaminated surfaces ( | 271 (68.3) | 126 (31.7) |
| Handling contaminated equipment ( | 294 (73.3) | 107 (26.7) |
| Splashes from contaminated fluids ( | 334 (83.9) | 64 (16.1) |
| Needle-stick injuries ( | 392 (92.7) | 31(7.3) |
| Cosmetic procedures ( | 249 (63.0) | 146 (37.0) |
| Dental procedures ( | 223 (59.2) | 154 (40.9) |
| Injecting drug use ( | 372 (89.2) | 45 (10.8) |
a All the modes listed are demonstrated modes of transmission of HBV [30]
Students’ responses to groups of people who should receive vaccination against HBV
| According to the World Health Organization (WHO) recommendation, who should be vaccinated against hepatitis B virus? | % | |
|---|---|---|
| Newborn babies ( | 199 | 53.1 |
| Children and adolescents who were not vaccinated in infancy( | 225 | 46.2 |
| Individuals with multiple sexual partners ( | 111 | 22.8 |
| Individuals seeking treatment for Sexually Transmitted Infections or Human Immunodeficiency Virus infection ( | 101 | 21.0 |
| Injecting drug users ( | 143 | 29.7 |
| Individuals whose jobs involve contact with blood ( | 352 | 73.0 |
| Patients undergoing dialysis ( | 123 | 25.5 |
| Individuals with chronic liver disease ( | 146 | 30.5 |
Students’ responses to whom they would recommend the vaccine and reasons for recommendation
| Would you recommend the HBV vaccine for the following groups of people? | Yes ( | No ( |
|---|---|---|
| Fellow students ( | 442 (97.8) | 10 (2.2) |
| Newborns ( | 233 (65.4) | 123 (34.6) |
| Infants ( | 234 (67.2) | 114(32.8) |
| Adolescents ( | 356 (90.6) | 37(9.4) |
| Adults ( | 345 (88.5) | 45 (11.5) |
| Why would you recommend the HBV vaccine? | ||
| To protect oneself (n = 449) | 445 (99.1) | 4 (0.9) |
| To protect patients ( | 338 (89.4) | 40 (10.6) |
| To protect your sexual partner ( | 261 (73.1) | 96 (26.9) |
| To protect others (n = 393) | 361 (91.9) | 32 (8.1) |
| To prevent mother-to-child transmission ( | 301 (80.3) | 74 (19.7) |
Fig. 3Students’ attitudes towards HBV vaccination and KMTC’s involvement in vaccination
Association of vaccine uptake with selected sociodemographic characteristics
| HBV Vaccination Status | Total | Pearson chi2 | ||||
|---|---|---|---|---|---|---|
| None a | Partial b | Full c | ||||
| Gender | ||||||
| Male | 30 | 122 | 43 | 195 | ||
| Female | 28 | 145 | 39 | 212 | ||
| Total | 58 | 349 | 82 | 407 | ||
| Campus | ||||||
| Kisii | 11 | 33 | 4 | 48 | ||
| Kakamega | 11 | 26 | 13 | 50 | ||
| Nairobi | 18 | 120 | 37 | 175 | ||
| Embu | 0 | 22 | 9 | 31 | ||
| Eldoret | 10 | 21 | 15 | 46 | ||
| Portreitz | 8 | 45 | 3 | 56 | ||
| Total | 58 | 267 | 81 | 406 | ||
| Department | ||||||
| Medical Laboratory Sciences | 18 | 33 | 17 | 68 | ||
| Nursing | 13 | 90 | 19 | 122 | ||
| Biomedical Engineering | 15 | 18 | 7 | 40 | ||
| Environmental Health | 0 | 22 | 9 | 31 | ||
| Physiotherapy | 0 | 14 | 4 | 18 | ||
| Imaging | 4 | 9 | 7 | 20 | ||
| Clinical Medicine | 1 | 46 | 8 | 55 | ||
| Pharmacy | 5 | 30 | 8 | 43 | ||
| Total | 56 | 262 | 79 | 397 | ||
| Year of Study | ||||||
| 1st year | 31 | 46 | 6 | 83 | ||
| 2nd year | 22 | 102 | 14 | 138 | ||
| 3rd year | 3 | 116 | 61 | 180 | ||
| 4th year | 2 | 2 | 1 | 5 | ||
| Total | 58 | 266 | 82 | 406 | ||
| Length of time as student | ||||||
| < 1 year | 31 | 38 | 5 | 74 | ||
| 1 year | 8 | 42 | 9 | 59 | ||
| 2 years | 9 | 74 | 12 | 95 | ||
| 3 years | 2 | 110 | 54 | 166 | ||
| > 4 years | 8 | 2 | 2 | 12 | ||
| Total | 58 | 266 | 82 | 406 | ||
a 0 vaccine doses received; b 1 or 2 vaccine doses received; c 3 or 4 vaccine doses received